Revenue
0 Unit_Standard_USD_KN3GwdxmikyW8H_kphyAbg
2023 Q1 · Unit_Standard_USD_KN3GwdxmikyW8H_kphyAbg
Exact inputs and evidence
- Revenue: 0 Unit_Standard_USD_KN3GwdxmikyW8H_kphyAbg Source
Fundies. English
PAXMEDICA, INC.
EDGAR15 filing records in this dataset, filed from 2020-07-02 to 2026-01-14. Reported financial figures are available; chart coverage varies by period.
Latest quarter
- Cash and cash equivalents
- 3.99 million Unit_Standard_USD_KN3GwdxmikyW8H_kphyAbg Source
Exact value
3986249 Unit_Standard_USD_KN3GwdxmikyW8H_kphyAbg
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 10.9 million shares Source
Exact value
10879170 shares
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-01-14.
Financial data available through: 2023-12-31.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage by financial measure
- Revenue: 1 of 11 periods available· newest 2023-12-31
- Operating income: 2 of 11 periods available· newest 2023-12-31
- Net income: 2 of 11 periods available· newest 2023-12-31
- Operating cash flow: 2 of 11 periods available· newest 2023-12-31
- capital expenditure: No compatible figures in this window
- Total assets: Multiple units; comparison withheld· newest 2023-12-31
- Total liabilities: Multiple units; comparison withheld· newest 2023-12-31
- Current assets: Multiple units; comparison withheld· newest 2023-12-31
- Current liabilities: Multiple units; comparison withheld· newest 2023-12-31
- Cash and cash equivalents: Multiple units; comparison withheld· newest 2022-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: Multiple units; comparison withheld· newest 2023-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 3.5 millionPrior period
−Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 14.8 million
–
Current period
−Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 18.3 million
–
Exact inputs and evidence
-18300000 − -14801767 = -3498233 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw
-14801767 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-18300000 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw · 2023-01-01 – 2023-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 4.73 millionPrior period
−Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 6.07 million
–
Current period
−Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 10.8 million
–
Exact inputs and evidence
-10800000 − -6071183 = -4728817 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw
-6071183 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-10800000 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw · 2023-01-01 – 2023-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2023 2023-01-01 – 2023-12-31
- Revenue Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 0
- Operating costs Derived Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 16.15 million
- Operating income −Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 16.15 million
- Tax, interest and other Derived Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 2.15 million
- Net income −Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 18.3 million
Cash
- Operating cash flow −Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 10.8 million
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2023 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 0 | 16145271 Derived | -16145271 | 2154729 Derived | -18300000 | Unavailable | Source
|
Amounts are exact, in Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 0 2023
Values and sources
| Period | Series | Value(Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 0 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | Not reported |
|
| 2023 | Net margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw -10.8M 2023
Values and sources
| Period | Series | Value(Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -10800000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Liabilities / assets | Not reported | No source recorded |
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Current assets / current liabilities | Not reported | No source recorded |
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | −Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 14.8 million Exact valueExact value: -14801767 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 2022-01-01 – 2022-12-31: -14801767 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 6.07 million Exact valueExact value: -6071183 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 2022-01-01 – 2022-12-31: -6071183 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 18.3 million Exact valueExact value: -18300000 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 2023-01-01 – 2023-12-31: -18300000 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 10.8 million Exact valueExact value: -10800000 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw 2023-01-01 – 2023-12-31: -10800000 Unit_Standard_USD_1y3eaVVnKk6IUhjPqH3CWw Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
15 filings · 1,049 latest values · 1,049 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001811623, 1811623, PXMD, edgar:1811623
Also known as KUVATRIS THERAPEUTICS, INC., Kuvatris Therapeutics, Inc., PAXMEDICA, INC., PAXMEDICA, INC., PaxMedica, Inc.